Pfiz­er boosts its gene ther­a­py work, bags up­start Bam­boo in $645M buy­out deal

Bam­boo Ther­a­peu­tics and its nascent gene ther­a­py pipeline is be­ing bought out by Pfiz­er, just five months af­ter the biotech raised close to $50 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.